Skip to content
Lower risk Drug recall · FDA · Published August 28, 2018

Humco Thyroid Levothyroxine Recall: Inconsistent Active Ingredients

Humco recalls thyroid medication with inconsistent levothyroxine and liothyronine levels. This may cause incorrect dosing. Contact Humco for details.

🇺🇸 FDA recall #D-0023-2019DrugHumco ›
Take action

Contact the company

Recalling firmHumco Holding Group, Inc7400 Alumax Rd · Texarkana, TX 75501-0282
✎ GovInfoNow plain-language explainer

What happened, in plain English

Humco is recalling thyroid medication that has inconsistent levels of active ingredients. This could lead to incorrect dosing and health issues if used without proper adjustment. Read more at govinfonow.com/recall/39671-humco-thyroid-levothyroxine-recall-inconsistent-active-ingredients.

Source Summary by GovInfoNow · govinfonow.com/recall/39671-humco-thyroid-levothyroxine-recall-inconsistent-active-ingredients · Updated October 6, 2026 · FDA enforcement record: FDA #D-0023-2019

Cite this page

“Humco Thyroid Levothyroxine Recall: Inconsistent Active Ingredients.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39671-humco-thyroid-levothyroxine-recall-inconsistent-active-ingredients. Based on FDA recall #D-0023-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0023-2019%22&limit=1).

Why it’s dangerous

The medication contains inconsistent levels of levothyroxine and liothyronine. This could result in incorrect dosing, potentially causing health issues if not adjusted by a healthcare provider.

Who’s affected

People prescribed this thyroid medication by a doctor. Those with thyroid conditions are most at risk.

How to tell if you have this one

Check for the product name 'Thyroid, USP (Porcine) Levothyroxine 36.3 mcg/grain Liothyronine 9.7 mcg/grain'. Look for NDC 0395-8077-62 on the packaging. The expiration dates range from 01/2019 to 06/2019.

  • Brand
    Humco
  • Category
    Drug
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide.
Recall numberProduct, codes & lotsQuantity
D-0022-2019Thyroid, USP (Porcine) Levothyroxine 36.3 mcg/grain Liothyronine 9.7 mcg/grain Active Pharmaceutical Ingredient Rx Only 1000 grams NDC 0395-8077-43 Packaged by: Humco Texarkana, TX 75501; Lots: A24542 Exp. 02/2019; A25528 Exp. 04/2019; A27119 Exp. 05/2019; A27810 Exp. 06/2019Unknown
D-0023-2019Thyroid, USP (Porcine) Levothyroxine 36.3 mcg/grain Liothyronine 9.7 mcg/grain Active Pharmaceutical Ingredient Rx Only 100 grams NDC 0395-8077-62 Packaged by: Humco Texarkana, TX 75501 USA; Lots: A24543 Exp. 02/2019; A25724 Exp. 01/2019; A25529 Exp. 04/2019; A25723 Exp. 04/2019; A27120 Exp. 05/2019; A27811 Exp. 06/2019; A28626 Exp. 06/2019; A29171 Exp. 06/2019; A29221 Exp. 06/2019Unknown.
D-0024-2019Thyroid, USP (Full Strength) Levothyroxine 112.1 mcg/grain Liothyronine 29.2 mcg/grain Active Pharmaceutical Ingredient Rx Only 1000 grams NDC 0395-6580-43 Packaged by: Humco Texarkana, TX 75501 USA; Lot: A26450 Exp. 05/201910 kilograms
Based on the official FDA remedy

What to do — step by step

  1. Check Medication Details

    Verify the product name and NDC code on the packaging to confirm if it's recalled.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 20 months after the firm started it.

1. Firm started the recall: Aug 28, 201812. FDA classified it Class II: Oct 12, 201823. Published in FDA’s Enforcement Report: Oct 24, 201834. FDA terminated the recall: May 7, 2020420182020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0023-2019 (August 28, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0023-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA